Cancer immunotherapy uses the immune system’s power to combat cancer by targeting tumor antigens presented by Human Leukocyte Antigen (HLA) molecules, also known as the Major Histocompatibility Complex (MHC) in vertebrates. The gene discussed is HLA-C; the disease is cancer.